To identify the candidate genes for pharmacogenetic studies of antipsychotic (AP)-induced extrapyramidal symptoms (EPS), we propose a systems biology analytical approach, based on protein–protein ...
Early acute extrapyramidal symptoms (EPS) are serious, debilitating and stigmatizing adverse effects of antipsychotics (AP). Although these side effects usually respond to dose reduction or to ...